摘要
抗血小板治疗作为冠心病二级预防的基石,与生活方式干预、控制冠心病危险因素起着同等重要的作用。抗血小板药物对冠心病二级预防拥有大量的临床循证医学证据,其主要包括环氧化酶-1抑制剂阿司匹林和二磷酸腺苷依赖的P2Y12拮抗剂、氯吡格雷、普拉格雷、替格瑞洛。现拟对目前临床上常用的抗血小板药物在冠心病二级预防中的应用做一综述。
Antiplatelet therapy represents an important pillar for secondary prevention of coronary artery disease along with lifestyle modification and control of cardiovascular risk factors. Oral antiplatelet agents for secondary prevention include the cyclo-oxygenase-1 inhibitor aspirin,and the ADP dependent P2Y12 inhibitors clopidogrel,prasugrel and ticagrelor. In this article we summarise the currently available evidence on choice of antiplatelet agents in various clinical settings.
出处
《心血管病学进展》
CAS
2015年第2期187-191,共5页
Advances in Cardiovascular Diseases
关键词
抗血小板
冠心病
二级预防
antiplatelet
coronary artery disease
secondary prevention
